Ofev (nintedanib) — United Healthcare
Idiopathic pulmonary fibrosis (IPF)
Initial criteria
- Diagnosis of idiopathic pulmonary fibrosis (IPF) as documented by all of the following:
- Exclusion of other known causes of interstitial lung disease (e.g., domestic and occupational environmental exposures, connective tissue disease, drug toxicity)
- ICD-10 Code J84.112 (Idiopathic pulmonary fibrosis)
- One of the following:
- In patients not subjected to surgical lung biopsy: presence of a usual interstitial pneumonia (UIP) pattern on HRCT revealing IPF or probable IPF
- In patients subjected to a lung biopsy: both HRCT and surgical lung biopsy pattern reveal IPF or probable IPF
- If request is for Esbriet, Esbriet is not used in combination with Ofev
- If request is for Ofev, Ofev is not used in combination with Esbriet
- Prescriber is a pulmonologist
Reauthorization criteria
- Documentation of positive clinical response to Esbriet or Ofev therapy, as applicable
- If Esbriet: not used in combination with Ofev
- If Ofev: not used in combination with Esbriet
Approval duration
12 months